A Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease

Clinical trial NCT01559363 · COMPLETED

Trial details

NCT number: NCT01559363
Sponsor: Kadmon, a Sanofi Company
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Polycystic Kidney, Autosomal Dominant

Start date: 2012-10-11
Primary completion: 2019-02-08
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.